Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib

Can J Ophthalmol. 2014 Apr;49(2):e49-52. doi: 10.1016/j.jcjo.2013.12.012.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Choroid Neoplasms / drug therapy*
  • Choroid Neoplasms / secondary
  • Humans
  • Indoles / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Middle Aged
  • Orbital Neoplasms / drug therapy*
  • Orbital Neoplasms / secondary
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf